title: Albumin-based nanoparticles as magnetic resonance contrast agents: I. Concept, first syntheses and characterisation.
abstract: To develop a platform for molecular magnetic resonance imaging, we prepared gadolinium-bearing albumin-polylactic acid nanoparticles in the size range 20-40 nm diameter. Iterative cycles of design and testing upscaled the synthesis procedures to gram amounts for physicochemical characterisation and for pharmacokinetic testing. Morphological analyses showed that the nanoparticles were spheroidal with rough surfaces. Particle sizes were measured by direct transmission electron microscopical measurements from negatively contrasted preparations, and by use of photon correlation spectroscopy; the two methods each documented nanoparticle sizes less than 100 nm and generally 10-40 nm diameter, though with significant intrabatch and interbatch variability. The particles' charge sufficed to hold them in suspension. HSA retained its tertiary structure in the particles. The nanoparticles were stable against turbulent flow conditions and against heat, though not against detergents. MRI imaging of liquid columns was possible at nanoparticle concentrations below 10 mg/ml. The particles were non-cytotoxic, non-thrombogenic and non-immunogenic in a range of assay systems developed for toxicity testing of nanoparticles. They were micellar prior to lyophilisation, but loosely structured aggregated masses after lyophilisation and subsequent resuspension. These nanoparticles provide a platform for further development, based on non-toxic materials of low immunogenicity already in clinical use, not expensive, and synthesized using methods which can be upscaled for industrial production.
authors.affiliation: Faculty of Health and Society, Malmö University, 205 06, Malmö, Sweden.
authors.forename: M M
authors.initials: MM
authors.lastname: Stollenwerk
authors.forename: I
authors.initials: I
authors.lastname: Pashkunova-Martic
authors.forename: C
authors.initials: C
authors.lastname: Kremser
authors.forename: H
authors.initials: H
authors.lastname: Talasz
authors.forename: G C
authors.initials: GC
authors.lastname: Thurner
authors.forename: A A
authors.initials: AA
authors.lastname: Abdelmoez
authors.forename: E A
authors.initials: EA
authors.lastname: Wallnöfer
authors.forename: A
authors.initials: A
authors.lastname: Helbok
authors.forename: E
authors.initials: E
authors.lastname: Neuhauser
authors.forename: N
authors.initials: N
authors.lastname: Klammsteiner
authors.forename: L
authors.initials: L
authors.lastname: Klimaschewski
authors.forename: E
authors.initials: E
authors.lastname: von Guggenberg
authors.forename: E
authors.initials: E
authors.lastname: Fröhlich
authors.forename: B
authors.initials: B
authors.lastname: Keppler
authors.forename: W
authors.initials: W
authors.lastname: Jaschke
authors.forename: P
authors.initials: P
authors.lastname: Debbage
mesh_terms: D000418:Albumins / Q000737:chemistry / Q000648:ultrastructure; D003287:Contrast Media / Q000737:chemistry*; D005682:Gadolinium / Q000737:chemistry*; D008279:Magnetic Resonance Imaging / Q000379:methods; D009682:Magnetic Resonance Spectroscopy; D046529:Microscopy, Electron, Transmission; D053758:Nanoparticles / Q000737:chemistry* / Q000648:ultrastructure*; D010316:Particle Size
chemical_list: D000418:Albumins; D003287:Contrast Media; D005682:Gadolinium